Trillium Ag is developing a portfolio of RNAi-based biologicals to improve crop protection, health and yield. Our product pipeline is based on the breakthrough RNAi trigger (MV-RNA, US Patent 9,200,276) and nanoparticles for transient or stable trait activation.
